ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,038,000 | +419.0% | 145,792 | +490.5% | 0.02% | +380.0% |
| Q2 2022 | $200,000 | -73.0% | 24,690 | -53.7% | 0.01% | -73.7% |
| Q1 2022 | $741,000 | -83.1% | 53,369 | -65.9% | 0.02% | -78.2% |
| Q4 2021 | $4,395,000 | +26.4% | 156,611 | +53.1% | 0.09% | +64.2% |
| Q3 2021 | $3,478,000 | +5.1% | 102,322 | +26.3% | 0.05% | +12.8% |
| Q2 2021 | $3,310,000 | +209.1% | 81,010 | +204.4% | 0.05% | +235.7% |
| Q1 2021 | $1,071,000 | -83.1% | 26,609 | -75.2% | 0.01% | -80.0% |
| Q4 2020 | $6,349,000 | – | 107,379 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |